Clinical Trials Browser

Phase EARLY_PHASE1 × Recurrence × Genitourinary × Clear all

NCT05559177 2022-09-29

An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer

Phase EARLY_PHASE1 Unknown

9 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Phase EARLY_PHASE1 Completed

2 enrolled

BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Uterine Neoplasms, Endometrial Neoplasms